Understanding how certain cells regenerate in the lungs after injury
Molecular control of a novel transitional cell state in alveolar regeneration
This study is looking at how lung cells heal after injury, especially focusing on a special type of cell that helps with recovery, and it aims to understand how certain factors guide this healing process, which could help people with lung conditions like COPD and pulmonary fibrosis.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10656356 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind lung cell regeneration, particularly focusing on a newly identified transitional cell state that plays a crucial role in the healing process after alveolar injury. Using advanced techniques like organoids and single-cell transcriptomics, the study aims to uncover how specific transcription factors influence the differentiation of lung cells during recovery. By examining the pathways involved in DNA damage and repair, the research seeks to provide insights into the cellular changes that occur in conditions like chronic obstructive pulmonary disease and pulmonary fibrosis.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from chronic obstructive pulmonary disease or pulmonary fibrosis.
Not a fit: Patients with acute lung injuries or those not diagnosed with chronic lung diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for improving lung regeneration and treating chronic lung diseases.
How similar studies have performed: Previous research has shown promise in understanding cellular regeneration mechanisms, but this specific approach focusing on the transitional cell state is relatively novel.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Tata, Purushothama Rao — Duke University
- Study coordinator: Tata, Purushothama Rao
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.